Articles

Q&A

As an Eli Lilly and Co. lobbyist in Washington, D.C., Jay Bonitt is hoping the Congressional “super committee” charged with trimming the federal budget doesn’t turn to the Medicare prescription drug program, known as Part D, to do so. Bonitt, Lilly's vice president of federal affairs, said the program is under budget and helps spur drugmakers to further innovation.

Read More

Deficit committee could bite CNO

Medicare supplement policies are reportedly one of the targets of Congress’ special deficit-reduction committee—and that’s not good news for Carmel-based CNO Financial Group Inc.

Read More

Feds support Planned Parenthood in defunding case

The U.S. Justice Department entered the court battle over a tough new Indiana abortion law that disqualifies Planned Parenthood of Indiana from the Medicaid program, siding with the organization in its request Thursday for a court order blocking the statute as unconstitutional.

Read More

Study: Indianapolis high-priced hospital market

Indianapolis-area hospitals have negotiated reimbursement rates with private health insurers that are two and three times higher than those paid by the federal Medicare program, suggesting the hospitals have the upper hand over insurers, according to a new study.

Read More